ENTITY
HBM Holdings Limited

HBM Holdings Limited (2142 HK)

68
Analysis
Health Care • China
Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases
more
Exchange Announcement • 14 Oct 2026 18:57

Next Day Disclosure Return

Exchange Announcement • 13 Oct 2026 20:59

Next Day Disclosure Return

Exchange Announcement • 21 Sep 2026 18:51

Supplemental Announcement In Relation To The 2025 Annual Report And The 2026 Interim Report

Exchange Announcement • 16 Sep 2026 18:00

Voluntary Announcement - Nona Biosciences Develops The World'S First Language Model Trained On Fully Human Heavy-Chain-Only Antibodies

Exchange Announcement • 10 Sep 2026 21:36

Interim Report 2026

x